Pharsight

TCR2 THERAPEUTICS INC PATENTS FACING OPPOSITIONS

Top patents of TCR2 THERAPEUTICS INC facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3298033B2 12 Jul, 2023 Compositions and medical uses for tcr reprogramming using fusion proteins May, 2036 1